Johnson & Johnson (JNJ)

131.65
1.54 1.18
NYSE : Health Technology
Prev Close 130.11
Open 131.00
Day Low/High 130.29 / 132.00
52 Wk Low/High 121.00 / 148.99
Volume 12.07M
Avg Volume 7.27M
Exchange NYSE
Shares Outstanding 2.64B
Market Cap 344.17B
EPS 5.70
P/E Ratio 21.50
Div & Yield 3.80 (2.85%)
How to Play the Long Side of Johnson & Johnson

How to Play the Long Side of Johnson & Johnson

Shares of the healthcare giant pick up a quant rating upgrade as the charts suggest gains ahead.

2 Trading Opportunities in Health Care

2 Trading Opportunities in Health Care

The potential of these setups on the weekly chart is rather good.

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

What's really surprising is the emergence of so many household names on the list.

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

The big story is about cloud adoption.

Where (and How) to Find 'Dividend Aristocrats'

Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Jim Cramer: Markets Seek Domestic Tranquility

Jim Cramer: Markets Seek Domestic Tranquility

Stock markets ran higher as investors turned towards domestic-focused companies.

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

It's hard to watch the market fall. But knowing you're still getting paid while it happens can make it much more palpable. That's why you need to have some dividend-producing stocks in your portfolio. Watch our video to find out why!

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were able to close the day in the green after a volatile day of trading.

Jim Cramer: Will the Techs Be Challenged, Too?

Jim Cramer: Will the Techs Be Challenged, Too?

The theft of intellectual property can be confronted by a Section 301 challenge directly from the trade representative.

An Updated Technical Strategy on Johnson & Johnson

An Updated Technical Strategy on Johnson & Johnson

Let's check and see how things are going.

Cramer: The Right Stocks Rallied Today

Cramer: The Right Stocks Rallied Today

Merger news, healthcare gains, industrials and even airlines joined the party.

Johnson & Johnson Poised to Move Higher, Buy Available Weakness

Johnson & Johnson Poised to Move Higher, Buy Available Weakness

With JNJ now set to close above $134, another look is in order.

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

We have a different kind of market where you must know the SYMBOLS and know what the companies do that are the symbols.

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

We could be poised for even a further advance PROVIDED that we stay oversold.

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over

How do the charts look now and is it safe to consider being a buyer again?

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

There is nothing wrong with Intel, Johnson & Johnson, 3M and Apple.

Cramer: This Is a Market Reset

Cramer: This Is a Market Reset

We are in a good-is-now-bad world.

Caution Flag Is Out on Johnson & Johnson's Stock

Caution Flag Is Out on Johnson & Johnson's Stock

With JPMorgan, Berkshire Hathaway and Amazon disrupting the health care space this morning a fresh look at JNJ is in order.

Dollar Decimation Creates Buy Opportunity

Dollar Decimation Creates Buy Opportunity

The time is right to buy this consumer products giant.

Cramer: Time to Throw Out The Old Rules

Cramer: Time to Throw Out The Old Rules

Stocks don't react to bad news the way they used to.

President Trump's Trade War Begins

President Trump's Trade War Begins

It's no secret that President Trump abhors trade deficits.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble

No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble

Our latest update on how to trade JNJ.

CVS Bans Photo Manipulation on Beauty Products, What You Need to Know

CVS Bans Photo Manipulation on Beauty Products, What You Need to Know

CVS bans photoshopping photos on its beauty products. Could it have a ripple effect for its suppliers like Procter & Gamble? Watch the video to learn more.

Jim Cramer: I Blame the Pajama Traders for This Selloff

Jim Cramer: I Blame the Pajama Traders for This Selloff

They make more irrational, stupid moves based on nothing than I ever thought possible.

Cramer: 5 Rules for Our Beast of a Bull Market

Cramer: 5 Rules for Our Beast of a Bull Market

It might look easy now, but it looked easy in 1999, too.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Novice Trade: Pfizer

Novice Trade: Pfizer

The trade for highly discretionary capital is the in-the-money, long call shooter expiring in January.

Cramer: 'Am I Diversified?' May Be Boring, but It Can Help Avoid the Pain

Cramer: 'Am I Diversified?' May Be Boring, but It Can Help Avoid the Pain

And on days like today, there can be a lot of it for some investors.